- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Biomaterial.
Displaying page 1 of 2.
EudraCT Number: 2018-004047-23 | Sponsor Protocol Number: 273551-2 | Start Date*: 2019-12-05 |
Sponsor Name:University of Bergen | ||
Full Title: Evaluation of safety and feasibility of autologous MSCs combined to biomaterial to enhance bone healing in patients with delayed consolidation after long bone defects requiring graft apposition or ... | ||
Medical condition: Diaphyseal and/or metaphysodiaphyseal fractures (femur, tibia, humerus) status delayed union (after 3 months) treated by standard care procedures | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005441-13 | Sponsor Protocol Number: C11-12 | Start Date*: 2013-01-03 | |||||||||||
Sponsor Name:INSERM | |||||||||||||
Full Title: Evaluation of efficacy and safety of autologous MSCs combined to biomaterials to enhance bone healing in patients with delayed consolidation after long bone fracture requiring graft apposition or ... | |||||||||||||
Medical condition: Closed or open Gustilo I ans II humerus, tibial or femur diaphyseal or metaphysodiaphyseal fracture. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003139-50 | Sponsor Protocol Number: Maxillo1 | Start Date*: Information not available in EudraCT |
Sponsor Name:University of Bergen, Faculty of medicin and dentistry, Dep. of Clinical Dentistry | ||
Full Title: International, multicenter phase II uncontrolled prospective clinical trial: Jaw bone reconstruction using a combination of biomaterial and autologous mesenchymal stem cells prior to dental impla... | ||
Medical condition: Men and women aged 18 years or more requiring jaw bone reconstruction prior to dental implant placement based on clinical and radiological examinations (CBCT Cone beam CT imaging). Areas suitable ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000431-32 | Sponsor Protocol Number: ORTHOUNION | Start Date*: 2017-05-25 | ||||||||||||||||
Sponsor Name:Universidad Autónoma de Madrid (U.A.M.) | ||||||||||||||||||
Full Title: A MULTI-CENTRE, OPEN-LABEL, RANDOMIZED, COMPARATIVE CLINICAL TRIAL OF TWO DIFFERENT DOSES OF BONE MARROW AUTOLOGOUS HUMAN MESENCHYMAL STEM CELLS PLUS BIOMATERIAL VERSUS ILIAC CREST AUTOLOGOUS GRAFT... | ||||||||||||||||||
Medical condition: Diaphyseal and/or metaphysodiaphyseal fractures (femur, tibia, humerus) with status of non-union | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) DE (Completed) FR (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004046-41 | Sponsor Protocol Number: 273551 | Start Date*: 2021-12-09 |
Sponsor Name:University of Bergen, | ||
Full Title: A multicentre clinical trial; Alveolar bone augmentation using Mesenchymal Stem Cells and biphasic calcium phosphate granules prior to dental implants | ||
Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000930-37 | Sponsor Protocol Number: STEMQUIRI/12ES01 | Start Date*: 2014-04-29 | |||||||||||
Sponsor Name:Laboratorios Salvat, S.A. | |||||||||||||
Full Title: A phase II clinical trial to assess the effect of HC-SVT-1001 (autologous fat stem adult mesenchymal cells expanded and combined with a tricalcium phosphate biomaterial) and HC-SVT-1002 (allogeneic... | |||||||||||||
Medical condition: Atrophic pseudarthrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001227-39 | Sponsor Protocol Number: 779322 | Start Date*: 2019-12-11 | |||||||||||
Sponsor Name:University of Bergen, Faculty of Medicin, Department of Clinical Dentistry | |||||||||||||
Full Title: A randomized controlled clinical trial to assess the efficacy of a combination of autologous mesenchymal stem cells and biomaterial in jaw bone regeneration prior to dental implant placement in com... | |||||||||||||
Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005599-33 | Sponsor Protocol Number: AMSC-BDT-001 | Start Date*: 2013-06-10 | |||||||||||
Sponsor Name:Lékařská fakulta Univerzity Karlovy v Hradci Králové | |||||||||||||
Full Title: Utilization of Autologous Multipotent Mesenchymal Stem Cells in the Management of the Large Skeletal Defects during Revision Total Hip Arthroplasty: a Prospective, Non-randomized, Open-Label Study ... | |||||||||||||
Medical condition: Revision total hip arthroplasty. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004623-36 | Sponsor Protocol Number: MEGALiT1901 | Start Date*: 2019-11-29 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: A MolEcularly Guided Anti-Cancer Drug Off-Label Trial – a multicenter, basket and umbrella explorative trial on the efficacy and safety of molecular profile selected commercially available targete... | ||
Medical condition: In part 1 of the study: any solid tumor with the exemption of sarcoma. In part 2: any solid tumor or hematological malignancy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000926-21 | Sponsor Protocol Number: AMSC-BDT-002 | Start Date*: 2016-10-06 | |||||||||||
Sponsor Name:Fakultní nemocnice Hradec Králové | |||||||||||||
Full Title: Innovation of method cryopreservation for clinical use autologous multipotent mesenchymal stem cells (MSCs) for treatment of extensive skeletal defects in revision surgery of total hip arthroplasty+ | |||||||||||||
Medical condition: Revision total hip arthroplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005431-86 | Sponsor Protocol Number: FuTuRe | Start Date*: 2014-02-10 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Evaluation of 18F-FDHT PET/CT as an early treatment response marker in patients with metastasized castration-resistant prostate cancer to be treated with enzalutamide. | ||
Medical condition: Castration-resistant prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006984-21 | Sponsor Protocol Number: MAXSEP | Start Date*: 2007-05-29 | |||||||||||
Sponsor Name:Friedrich-Schiller-University of Jena | |||||||||||||
Full Title: prospective, randomized, open, multicentre trial to assess the influence of empiric antibiotic monotherapy with meropenem (Meronem) versus combination with moxifloxacin (Avalox) on the organ functi... | |||||||||||||
Medical condition: severe sepsis / septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000957-47 | Sponsor Protocol Number: 12052004 | Start Date*: 2007-11-22 |
Sponsor Name:Charité | ||
Full Title: Comparison of Bisoprolol and Carvedilol in elderly patients with heart failure. A randomised doubleblind multicenter trial | ||
Medical condition: Patients, 65 years or older, suffering from chronic heart failure and who are so far not treated with betablockers or treated with a low dose betablocker (<1/4 standard dose) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005834-19 | Sponsor Protocol Number: GBG44 | Start Date*: 2007-10-27 |
Sponsor Name:GBG Forschungs GmbH | ||
Full Title: A phase III trials program exploring the integration of Bevacizumab, Everolimus (RAD001), and Lapatinib into current neoadjuvant chemotherapy regimes for primary breast cancer | ||
Medical condition: breast cancer, primary systemic therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001784-36 | Sponsor Protocol Number: PAED-201601 | Start Date*: 2019-08-12 |
Sponsor Name:Rheinische Friedrich-Wilhelms-Universität Bonn | ||
Full Title: Multicentre prospective trial for extracranial malignant germ cell tumours including a randomized comparison of Carboplatin and Cisplatin | ||
Medical condition: Extracranial germ cell tumours of any malignant histology, primary site and stage | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) AT (Ongoing) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002736-31 | Sponsor Protocol Number: ETOP22-22 | Start Date*: 2023-05-04 | |||||||||||
Sponsor Name:ETOP IBCSG Partners Foundation | |||||||||||||
Full Title: A multicentre, single-arm phase II trial of adagrasib in patients with KRASG12C-mutant NSCLC, including the elderly (≥70 years) or patients with poor performance status | |||||||||||||
Medical condition: Patients with KRASG12C-mutant stage IV NSCLC that had prior chemotherapy and/or immune-checkpoint inhibition or both. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Trial now transitioned) IT (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004333-42 | Sponsor Protocol Number: SISPCT | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Friedrich-Schiller-University of Jena | |||||||||||||
Full Title: Prospective randomized clinical multicenter trial about the effect of an adjunctive intravenous treatment with sodium selenite (selenase®T, double-blind) and a procalcitonin guided causal therapy (... | |||||||||||||
Medical condition: severe sepsis / septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015122-11 | Sponsor Protocol Number: GBG54 | Start Date*: 2012-08-27 | |||||||||||
Sponsor Name:GBG Forschungs GmbH | |||||||||||||
Full Title: A prospective, randomised multi-centre phase II study evaluating the adjuvant, neoadjuvant or palliative treatment with tamoxifen +/- GnRH analogue versus aromatase inhibitor + GnRH analogue in m... | |||||||||||||
Medical condition: Breast Cancer in Male Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004539-54 | Sponsor Protocol Number: TMP-0731-2018 | Start Date*: 2019-06-03 |
Sponsor Name:Fraunhofer-Institute for Translational Medicine and Pharmacology ITMP | ||
Full Title: Capability of Tofacitinib or Etanercept to accelerate clinical relevant tapering of non-steroidal anti-inflammatory drugs and treat-to-target guided de-escalation of corticosteroids in patients wit... | ||
Medical condition: Patients with active Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003156-21 | Sponsor Protocol Number: ETOP_5-12/EORTC_08111 | Start Date*: 2014-12-19 | |||||||||||
Sponsor Name:ETOP (European Thoracic Oncology Platform) | |||||||||||||
Full Title: A randomised, open-label phase III trial evaluating the addition of denosumab to standard first-line anticancer treatment in advanced NSCLC | |||||||||||||
Medical condition: advanced NSCLC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) IT (Completed) IE (Completed) DE (Completed) GB (Completed) AT (Completed) ES (Completed) SI (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.